|
The Biodesign Institute, launched by Arizona State University (ASU) in 2004, promotes interdisciplinary bioscience, engineering, and computing research. The organization includes applied nanobioscience, bio-optical nanotechnology, ecogenomics, environmental biotechnology, infectious disease and vaccinology, medicine, single molecule biophysics, and other research centers. It is developing disease diagnosis, explosives detection, DNA forensics, renewable energy, water treatment, and flexible electronic display technologies. The institute collaborates with ASU's commercialization division, Arizona Technology Enterprises (AzTE). AzTE identifies research that has market potential. The unit handles licensing, industry partnership, and company development operations. The Biodesign Institute filed 17 patent applications and launched three spin-out companies in 2004. The organization initially was funded with K-12 education and university research taxes. It also raises funds from government, industry, and philanthropic institutions. The Biodesign Institute's 350,000 square foot research facility has won recognition from 'R&D Magazine.'
|